#diabteticretinopathy

  1. OCS-01 eye drops meet primary, secondary endpoints in diabetic macular edema phase 3 trial

    OCS-01 eye drops met the primary and secondary endpoints for the treatment of diabetic macular edema in stage 1 of the phase 3 DIAMOND trial. Changing from an eye injection to an eye drop would be a game changer for our patients with #DME #clinicaltrial #eye #health #vision #diabe